The pathophysiology of restenosis involves early elements of direct injury to smooth muscle
cells, deendothelialization, and thrombus deposition. Over time, this leads to smooth muscle …

High-sensitivity C-reactive protein (hsCRP) is a marker of inflammation that predicts incident
myocardial infarction, stroke, peripheral arterial disease, and sudden cardiac death among …

Next is a granulation or cellular proliferation phase. Growth factors are subsequently
released from platelets, leukocytes, and SMCs, which stimulate migration of SMCs from the …

were identified at relatively high frequency (compared with control subjects or patients with
effort angina) in the peripheral blood. 14 Using an experimental canine model, Eguchi et …

During the past three decades, percutaneous coronary intervention has become one of the
cardinal treatment strategies for stenotic coronary artery disease. Technical advances …

Background: C-reactive protein (CRP) can provide prognostic information about the risk of
developing atherosclerotic complications in apparently healthy patients. This new clinical …

OBJECTIVES We sought to investigate whether early and late outcome after percutaneous
transluminal coronary angioplasty (PTCA) could be predicted by baseline levels of acute …

C-reactive protein (CRP) is a non-specific biomarker of inflammation. Recent research has
shown that inflammation is an important step in the genesis of atherosclerosis, and is …

Background Established methods of risk assessment in percutaneous coronary intervention
have focused on clinical and anatomical lesion characteristics. Emerging evidence indicates …

The role of inflammation in the development of restenosis after percutaneous coronary
interventions has been investigated in several studies. There is an interaction of …